Michael P. Murphy

Michael P. Murphy is a finance professional with extensive experience in biotechnology and therapeutic development. Currently serving as Controller at HiFiBiO Therapeutics since May 2024, Michael is involved in enhancing immunotherapy success through innovative solutions combining single-cell capabilities with AI/ML. Prior roles include Assistant Controller positions at multiple Flagship Labs entities and other biotech companies, reflecting a robust background in accounting management within high-impact environments. Michael holds a Bachelor of Science degree with a double major in Accounting and Finance from Bridgewater State University.